These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2151892

  • 1. Early nicotinamide treatment in the NOD mouse: effects on diabetes and insulitis suppression and autoantibody levels.
    Reddy S, Bibby NJ, Elliott RB.
    Diabetes Res; 1990 Oct; 15(2):95-102. PubMed ID: 2151892
    [Abstract] [Full Text] [Related]

  • 2. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [Abstract] [Full Text] [Related]

  • 3. Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
    Beales PE, Williams A, Krug J, Signore A, Chianelli M, Andreani D, Pozzilli P.
    Diabete Metab; 1992 May; 18(1):48-53. PubMed ID: 1563537
    [Abstract] [Full Text] [Related]

  • 4. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P, Ji RC, Shimoda H, Miura M, Kato S.
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [Abstract] [Full Text] [Related]

  • 5. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F, Yu M, Zhu Q.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [Abstract] [Full Text] [Related]

  • 6. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M.
    Cell Immunol; 1993 Apr 15; 148(1):189-97. PubMed ID: 8098666
    [Abstract] [Full Text] [Related]

  • 7. Splenocytes from non-obese-diabetic mice binding to xenogeneic beta-cells in vitro: an early marker of cell-mediated immunity.
    Martignat L, Feve B, Charbonnel B, Sai P.
    Diabete Metab; 1993 Apr 15; 19(6):566-74. PubMed ID: 8026608
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse.
    Hawa MI, Valorani MG, Buckley LR, Beales PE, Afeltra A, Cacciapaglia F, Leslie RD, Pozzilli P.
    Horm Metab Res; 2004 Sep 15; 36(9):620-4. PubMed ID: 15486813
    [Abstract] [Full Text] [Related]

  • 9. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ, French MB, Chosich N, Harrison LC.
    J Autoimmun; 1994 Oct 15; 7(5):643-53. PubMed ID: 7840856
    [Abstract] [Full Text] [Related]

  • 10. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL.
    J Immunol; 1997 Nov 15; 159(10):4686-92. PubMed ID: 9366391
    [Abstract] [Full Text] [Related]

  • 11. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A, Suarez WL, Power RF.
    J Lab Clin Med; 1993 Apr 15; 121(4):603-7. PubMed ID: 8454942
    [Abstract] [Full Text] [Related]

  • 12. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A, Rosmalen JG, Homo-Delarche F, Dardenne M, Drexhage HA.
    J Autoimmun; 1996 Jun 15; 9(3):341-8. PubMed ID: 8816969
    [Abstract] [Full Text] [Related]

  • 13. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V, Toseland CD, Turner NC.
    Metabolism; 2000 Dec 15; 49(12):1548-54. PubMed ID: 11145115
    [Abstract] [Full Text] [Related]

  • 14. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ, Zhou ZG, Su H.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug 15; 31(4):499-504. PubMed ID: 16951506
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I, Fabien N, Thivolet C.
    Diabetes Metab; 1996 Jul 15; 22(4):235-9. PubMed ID: 8767168
    [Abstract] [Full Text] [Related]

  • 20. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S, Bai Y, Robinson E, Ross J.
    Ann N Y Acad Sci; 2006 Oct 15; 1079():103-8. PubMed ID: 17130538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.